Annual report pursuant to Section 13 and 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.19.1
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487  
Gross Unrealized Gains 812,120  
Value 1,567,607 $ 1,552,090
Cost Basis   755,487
Gross Unrealized Gains   718,463
Value   1,473,950
Common stocks    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487  
Gross Unrealized Gains 812,120  
Value $ 1,567,607  
Cost Basis   755,487
Gross Unrealized Gains   718,463
Value   $ 1,473,950